The Hematology [HEME] IRG will consider research applications ranging from basic research through clinical studies focused on hematopoiesis, blood cells and their diseases and studies of normal and pathologic hemostasis and thrombosis. Specific areas include hemoglobinopathies, thalassemias, iron and heme metabolism, red cell and granuloctye/monocyte/leukocyte biology, transfusion medicine, disorders and parasite infections that involve blood elements, basic and applied aspects of normal and abnormal hematopoiesis, leukemias and leukomogenesis, hematopoietic stem cell transplantation, hematopoietic cell gene therapy, mechanisms of hemostasis and thrombosis, megakaryocytopoiesis involving platelet production and gene therapy of disease involving blood coagulation factors (hemophilia). Evaluation of single site clinical studies of hematologic disorders will be considered in a separate special emphasis panel as needed.
The following Study Sections are included within the HEME IRG:
|